Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Gross Margin (2016 - 2025)

Historic Gross Margin for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to 81.66%.

  • Sanofi's Gross Margin fell 16500.0% to 81.66% in Q4 2025 from the same period last year, while for Dec 2025 it was 63.28%, marking a year-over-year decrease of 140900.0%. This contributed to the annual value of 77.17% for FY2025, which is 15100.0% up from last year.
  • Sanofi's Gross Margin amounted to 81.66% in Q4 2025, which was down 16500.0% from 78.02% recorded in Q3 2025.
  • Over the past 5 years, Sanofi's Gross Margin peaked at 83.31% during Q4 2024, and registered a low of 39.54% during Q2 2025.
  • Its 5-year average for Gross Margin is 73.4%, with a median of 74.48% in 2023.
  • In the last 5 years, Sanofi's Gross Margin plummeted by -5971900bps in 2021 and then skyrocketed by 85300bps in 2024.
  • Sanofi's Gross Margin (Quarter) stood at 69.44% in 2021, then increased by 4bps to 72.0% in 2022, then rose by 4bps to 74.78% in 2023, then increased by 11bps to 83.31% in 2024, then decreased by -2bps to 81.66% in 2025.
  • Its Gross Margin stands at 81.66% for Q4 2025, versus 78.02% for Q3 2025 and 39.54% for Q2 2025.